NCT06563947View on ClinicalTrials.gov

Single Arm Clinical Trial (Gut Microbiota and HCC)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 24, 2024

Primary Completion Date

May 20, 2026

Study Completion Date

November 20, 2026

Conditions
Liver Cancer
Interventions
BIOLOGICAL

Oral enterobacterium capsules

Enterobacterium capsules (300 mg/per capsule) orally 6 capsules/day for 10 consecutive days.

All Listed Sponsors
collaborator

Nanjing Xiershou Biotechnology Co., Ltd

UNKNOWN

lead

Xu Yong, MD

OTHER

NCT06563947 - Single Arm Clinical Trial (Gut Microbiota and HCC) | Biotech Hunter | Biotech Hunter